Ketamine Queen, Jasveen Sangha, travelled to Japan few days after Matthew Perry's death

Instagram Story posts from Sangha’s personal account showed that she went to Japan starting around Nov. 8, 2023.


Pop Culture & Art August 19, 2024
Courtesy: Reuters

Jasveen Sangha, the alleged underground drug dealer known as the “Ketamine Queen” and charged in connection with Matthew Perry’s death, traveled abroad just days after the “Friends” star was discovered dead in his home.

Instagram Story posts from Sangha’s personal account showed that she went to Japan starting around Nov. 8, 2023, which is 11 days after Perry died from the “acute effects of ketamine.”

The Los Angeles resident expressed her delight in the posts over the luxurious experiences she had, such as dining at Signature, a French restaurant located inside the Mandarin Oriental hotel in Tokyo.

In one post, she was seen casually posing while taking a mirror selfie at an immersive museum.

Sangha captioned a photo of her sushi meal, “Happy girl.”

Her international travels didn’t end there, as three months later she flew to Mexico.

Instagram Story posts from her trip south showed Sangha hanging out with friends by the pool and enjoying several cocktails.

After a sound bath, she captioned one post, “Sound healing was absolutely uplifting and cleansing for the heart & soul.”

Sangha’s friends exclusively told The Post on Friday that the so-called “Ketamine Queen” appeared “carefree” after Perry’s death and continued to maintain an active social life.

“If anything, she became more social in the past few months,” a longtime friend said. “She seemed carefree, like she didn’t have a worry in the world.”

The friend added that Sangha was “always up for parties or dinner or just hanging out.”

“She put on a brave face, considering what she knew was coming,” the source said. “She acted like it was no big deal at all,” as Page Six reported. 

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ